In this article and its corresponding editorial, there are 5 questions that can take the place of ordering coagulation studies prior to every bronchoscopy.
These five clinical risk factors are as follows
- history of anticoagulant therapy
- history or physical evidence of liver disease, eg, hepatitis, cirrhosis, hepatomegaly, ascites, or jaundice
- history, family history, or physical evidence of bleeding tendencies, eg, prolonged, delayed, or excessive bleeding, ecchymosis, hematoma, purpura, or petechiae
- active bleeding and/or preoperative transfusion therapy
- no reliable history available
If none are present, coagulation studies do not predict clinical bleeding and are not likely to be cost effective.
